Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Wnt Inducible Signaling Pathway Protein 1 (WISP1), also known as CCN4, is a member of the CCN family of matricellular proteins. Its expression is induced by the Wnt/β-catenin signaling pathway. WISP1 regulates various cellular processes including cell adhesion, proliferation, differentiation, survival, and motility. It plays a role in bone development, fibrosis (pulmonary and kidney), inflammation, and cancer by interacting with integrins and modulating downstream signaling pathways such as FAK, RAS-MAPK, NF-kB, TGF-beta, and PI3K-Akt. In kidney inflammation, WISP1 induces macrophage accrual/inflammatory cytokine production via NF-kB, and its blockade attenuates kidney inflammation/fibrosis.
WISP1 binds to multiple cell-surface integrins through its conserved domains (IGFBP-like, vWC, TSR, CT) to regulate intracellular signals including FAK, RAS-MAPK, NF-kB, TGF-beta, and PI3K-Akt pathways. It acts via multiligand interactions typical for matricellular proteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wnt Inducible Signaling Pathway Protein 1 (WISP1).